NCEL Stock Analysis: Buy, Sell, or Hold?
$3.35
0.06 (1.82%)
▲
5d:
-0.89%
30d:
-2.9%
90d:
+6.01%
BUY
MODERATE Confidence
Analysis Updated: Sep 2, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When NCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NCEL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: NCEL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NCEL is currently trading at $3.35, which is considered fair relative to its 30-day fair value range of $3.27 to $3.49.
Technical Outlook: Technically, NCEL is showing sideways momentum. Immediate support is located at $3.17, while resistance sits at $3.60.
Market Sentiment: NCEL scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $23.00 (+586.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NCEL is showing sideways momentum. Immediate support is located at $3.17, while resistance sits at $3.60.
Market Sentiment: NCEL scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $23.00 (+586.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.27 -
$3.49
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (67/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 586.6% below Wall St target ($23.00)
- BULLISH: Bottoming setup score 67/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$3.27 -
$3.49
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.17
Resistance Level
$3.60
Current Trend
Sideways
Technical data as of
Sep 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.58
Wall Street Target
$23.00
(+586.6%)
Share & Embed Analysis
Last updated: September 03, 2026 12:30 AM ET
Data refreshes hourly during market hours. Next update: 1:30 AM
Data refreshes hourly during market hours. Next update: 1:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 52 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 45 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 52 HOLD |
|
SMMT
Summit Therapeutics PLC |
STRONG BUY
10 analysts |
$28 | 52 HOLD |